Viveve Medical, Inc. (VIVE)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2021 | 25.91 Million USD | 55.82% |
| 2020 | 16.63 Million USD | -38.35% |
| 2019 | 26.97 Million USD | -42.4% |
| 2018 | 46.83 Million USD | 29.81% |
| 2017 | 36.07 Million USD | 147.98% |
| 2016 | 14.54 Million USD | 26.58% |
| 2015 | 11.49 Million USD | 400.17% |
| 2014 | 2.29 Million USD | 47.5% |
| 2013 | 1.55 Million USD | 42.8% |
| 2012 | 1.09 Million USD | -69.26% |
| 2011 | 3.54 Million USD | 7.06% |
| 2010 | 3.31 Million USD | -34.25% |
| 2009 | 5.04 Million USD | -36.28% |
| 2008 | 7.91 Million USD | -29.35% |
| 2007 | 11.2 Million USD | -15.0% |
| 2006 | 13.17 Million USD | 5.69% |
| 2005 | 12.46 Million USD | -6.45% |
| 2004 | 13.32 Million USD | 35.31% |
| 2003 | 9.84 Million USD | -4.64% |
| 2002 | 10.32 Million USD | -16.02% |
| 2001 | 12.29 Million USD | -18.44% |
| 2000 | 15.07 Million USD | -1.57% |
| 1999 | 15.31 Million USD | -6.02% |
| 1998 | 16.3 Million USD | -39.63% |
| 1997 | 27 Million USD | 39.18% |
| 1996 | 19.4 Million USD | 6.01% |
| 1995 | 18.3 Million USD | 27.97% |
| 1994 | 14.3 Million USD | 88.16% |
| 1993 | 7.6 Million USD | 11.76% |
| 1992 | 6.8 Million USD | 28.3% |
| 1991 | 5.3 Million USD | 0.0% |
| 1990 | - USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 Q1 | 20.68 Million USD | -20.18% |
| 2022 Q3 | 12.15 Million USD | -21.53% |
| 2022 Q2 | 15.48 Million USD | -25.12% |
| 2021 Q4 | 25.91 Million USD | -14.71% |
| 2021 FY | 25.91 Million USD | 55.82% |
| 2021 Q1 | 37.67 Million USD | 126.52% |
| 2021 Q2 | 34.02 Million USD | -9.67% |
| 2021 Q3 | 30.38 Million USD | -10.71% |
| 2020 Q1 | 21.43 Million USD | -20.55% |
| 2020 Q3 | 19.92 Million USD | -2.95% |
| 2020 Q2 | 20.53 Million USD | -4.2% |
| 2020 FY | 16.63 Million USD | -38.35% |
| 2020 Q4 | 16.63 Million USD | -16.54% |
| 2019 Q1 | 34.85 Million USD | -25.58% |
| 2019 Q4 | 26.97 Million USD | 11.71% |
| 2019 FY | 26.97 Million USD | -42.4% |
| 2019 Q2 | 25.49 Million USD | -26.84% |
| 2019 Q3 | 24.14 Million USD | -5.28% |
| 2018 Q2 | 48.85 Million USD | -13.75% |
| 2018 Q1 | 56.63 Million USD | 56.98% |
| 2018 FY | 46.83 Million USD | 29.81% |
| 2018 Q4 | 46.83 Million USD | 28.53% |
| 2018 Q3 | 36.43 Million USD | -25.41% |
| 2017 Q1 | 39.97 Million USD | 174.76% |
| 2017 FY | 36.07 Million USD | 147.98% |
| 2017 Q4 | 36.07 Million USD | 8.97% |
| 2017 Q3 | 33.1 Million USD | -17.04% |
| 2017 Q2 | 39.91 Million USD | -0.16% |
| 2016 Q1 | 8.66 Million USD | -24.61% |
| 2016 Q2 | 23.06 Million USD | 166.17% |
| 2016 Q3 | 19.1 Million USD | -17.16% |
| 2016 Q4 | 14.54 Million USD | -23.86% |
| 2016 FY | 14.54 Million USD | 26.58% |
| 2015 Q3 | 8.93 Million USD | -16.93% |
| 2015 FY | 11.49 Million USD | 400.17% |
| 2015 Q1 | 1.63 Million USD | -28.89% |
| 2015 Q4 | 11.49 Million USD | 28.68% |
| 2015 Q2 | 10.75 Million USD | 558.08% |
| 2014 Q4 | 2.29 Million USD | -27.03% |
| 2014 Q3 | 3.14 Million USD | 336.8% |
| 2014 Q2 | 721 Thousand USD | 19.37% |
| 2014 Q1 | 604 Thousand USD | -61.23% |
| 2014 FY | 2.29 Million USD | 47.5% |
| 2013 Q1 | 3.56 Million USD | 226.95% |
| 2013 Q3 | 2.48 Million USD | 9.23% |
| 2013 Q2 | 2.27 Million USD | -36.22% |
| 2013 FY | 1.55 Million USD | 42.8% |
| 2013 Q4 | 1.55 Million USD | -37.3% |
| 2012 Q1 | 2.55 Million USD | -28.09% |
| 2012 Q4 | 1.09 Million USD | -39.05% |
| 2012 Q3 | 1.79 Million USD | -2.51% |
| 2012 Q2 | 1.83 Million USD | -28.06% |
| 2012 FY | 1.09 Million USD | -69.26% |
| 2011 FY | 3.54 Million USD | 7.06% |
| 2011 Q4 | 3.54 Million USD | -11.78% |
| 2011 Q3 | 4.02 Million USD | -18.76% |
| 2011 Q2 | 4.95 Million USD | -17.81% |
| 2011 Q1 | 6.02 Million USD | 81.75% |
| 2010 Q4 | 3.31 Million USD | -2.47% |
| 2010 Q1 | 4.23 Million USD | -16.1% |
| 2010 FY | 3.31 Million USD | -34.25% |
| 2010 Q2 | 3.81 Million USD | -9.74% |
| 2010 Q3 | 3.39 Million USD | -10.97% |
| 2009 FY | 5.04 Million USD | -36.28% |
| 2009 Q1 | 6.73 Million USD | -14.85% |
| 2009 Q2 | 6.29 Million USD | -6.53% |
| 2009 Q3 | 5.92 Million USD | -5.94% |
| 2009 Q4 | 5.04 Million USD | -14.89% |
| 2008 Q1 | 10.29 Million USD | -8.06% |
| 2008 Q2 | 8.78 Million USD | -14.69% |
| 2008 Q4 | 7.91 Million USD | -6.93% |
| 2008 FY | 7.91 Million USD | -29.35% |
| 2008 Q3 | 8.5 Million USD | -3.21% |
| 2007 FY | 11.2 Million USD | -15.0% |
| 2007 Q2 | 11.97 Million USD | -4.21% |
| 2007 Q4 | 11.2 Million USD | -6.32% |
| 2007 Q3 | 11.95 Million USD | -0.19% |
| 2007 Q1 | 12.5 Million USD | -5.1% |
| 2006 Q2 | 13.77 Million USD | 1.76% |
| 2006 Q1 | 13.54 Million USD | 8.61% |
| 2006 FY | 13.17 Million USD | 5.69% |
| 2006 Q4 | 13.17 Million USD | -2.55% |
| 2006 Q3 | 13.52 Million USD | -1.87% |
| 2005 Q1 | 13.52 Million USD | 1.49% |
| 2005 Q4 | 12.46 Million USD | -4.0% |
| 2005 Q2 | 13.37 Million USD | -1.12% |
| 2005 FY | 12.46 Million USD | -6.45% |
| 2005 Q3 | 12.98 Million USD | -2.89% |
| 2004 Q3 | 13.38 Million USD | -3.79% |
| 2004 FY | 13.32 Million USD | 35.31% |
| 2004 Q1 | 14.56 Million USD | 47.85% |
| 2004 Q2 | 13.91 Million USD | -4.45% |
| 2004 Q4 | 13.32 Million USD | -0.45% |
| 2003 FY | 9.84 Million USD | -4.64% |
| 2003 Q4 | 9.84 Million USD | -2.04% |
| 2003 Q3 | 10.05 Million USD | -3.64% |
| 2003 Q2 | 10.43 Million USD | 3.42% |
| 2003 Q1 | 10.08 Million USD | -2.31% |
| 2002 Q2 | 10.99 Million USD | -0.04% |
| 2002 Q1 | 10.99 Million USD | -10.56% |
| 2002 FY | 10.32 Million USD | -16.02% |
| 2002 Q4 | 10.32 Million USD | -6.77% |
| 2002 Q3 | 11.07 Million USD | 0.75% |
| 2001 Q3 | 13.59 Million USD | -9.46% |
| 2001 Q2 | 15.01 Million USD | -8.65% |
| 2001 Q1 | 16.43 Million USD | 9.01% |
| 2001 FY | 12.29 Million USD | -18.44% |
| 2001 Q4 | 12.29 Million USD | -9.54% |
| 2000 Q4 | 15.07 Million USD | -13.86% |
| 2000 Q2 | 18.46 Million USD | -0.97% |
| 2000 Q1 | 18.64 Million USD | 21.69% |
| 2000 FY | 15.07 Million USD | -1.57% |
| 2000 Q3 | 17.5 Million USD | -5.18% |
| 1999 Q3 | 15.9 Million USD | 3.92% |
| 1999 FY | 15.31 Million USD | -6.02% |
| 1999 Q1 | 15.8 Million USD | -3.07% |
| 1999 Q2 | 15.3 Million USD | -3.16% |
| 1999 Q4 | 15.31 Million USD | -3.65% |
| 1998 Q2 | 23.7 Million USD | -0.42% |
| 1998 Q4 | 16.3 Million USD | -17.68% |
| 1998 Q3 | 19.8 Million USD | -16.46% |
| 1998 Q1 | 23.8 Million USD | -11.85% |
| 1998 FY | 16.3 Million USD | -39.63% |
| 1997 Q2 | 14.9 Million USD | -10.24% |
| 1997 Q3 | 30.1 Million USD | 102.01% |
| 1997 Q4 | 27 Million USD | -10.3% |
| 1997 FY | 27 Million USD | 39.18% |
| 1997 Q1 | 16.6 Million USD | -14.43% |
| 1996 Q2 | 21.3 Million USD | -4.48% |
| 1996 Q3 | 20.7 Million USD | -2.82% |
| 1996 Q4 | 19.4 Million USD | -6.28% |
| 1996 FY | 19.4 Million USD | 6.01% |
| 1996 Q1 | 22.3 Million USD | 21.86% |
| 1995 FY | 18.3 Million USD | 27.97% |
| 1995 Q4 | 18.3 Million USD | 0.0% |
| 1994 Q2 | 6.8 Million USD | -1.45% |
| 1994 Q3 | 14.2 Million USD | 108.82% |
| 1994 FY | 14.3 Million USD | 88.16% |
| 1994 Q4 | 14.3 Million USD | 0.7% |
| 1994 Q1 | 6.9 Million USD | -9.21% |
| 1993 Q2 | 9 Million USD | 40.63% |
| 1993 Q4 | 7.6 Million USD | -8.43% |
| 1993 Q3 | 8.3 Million USD | -7.78% |
| 1993 FY | 7.6 Million USD | 11.76% |
| 1993 Q1 | 6.4 Million USD | -5.88% |
| 1992 FY | 6.8 Million USD | 28.3% |
| 1992 Q3 | 8 Million USD | 70.21% |
| 1992 Q4 | 6.8 Million USD | -15.0% |
| 1992 Q2 | 4.7 Million USD | -9.62% |
| 1992 Q1 | 5.2 Million USD | -1.89% |
| 1991 FY | 5.3 Million USD | 0.0% |
| 1991 Q4 | 5.3 Million USD | 0.0% |
| 1990 FY | - USD | 0.0% |
| 1990 Q4 | - USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acutus Medical, Inc. | 53.96 Million USD | 51.977% |
| Biotricity, Inc. | 5.94 Million USD | -336.053% |
| Cell MedX Corp. | 46.12 Thousand USD | -56083.6% |
| Dynatronics Corporation | 25.94 Million USD | 0.106% |
| Nemaura Medical Inc. | 14.56 Million USD | -77.934% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -731.81% |
| RetinalGenix Technologies Inc. | 156.00 USD | -16610797.436% |
| Sonendo, Inc. | 78.16 Million USD | 66.846% |
| Telesis Bio, Inc. | 70.41 Million USD | 63.198% |
| Talis Biomedical Corporation | 98.34 Million USD | 73.65% |